Veterinary Medicines

Albex 2.5 % Oral Suspension

Authorised
  • Albendazole
Download as PDF

Product identification

Medicine name:
Albex 2.5 % Oral Suspension
Active substance:
  • Albendazole
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    2.50
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        60
        hour
    • Sheep
      • Meat and offal
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 1.0 L white standard containersStandard PackContainer: HDPEClosure: HDPECap liner: Expanded polyethyleneTamper evidence: Closure is tamper evident
  • 2.5 L white standard containers.Standard PackContainer: HDPEClosure: HDPECap liner: Expanded polyethyleneTamper evidence: Closure is tamper evident
  • 5.0 L white standard containers.Standard PackContainer: HDPEClosure: HDPECap liner: Expanded polyethyleneTamper evidence: Closure is tamper evident
  • 10 L white standard containers.Standard PackContainer: HDPEClosure: HDPECap liner: Expanded polyethyleneTamper evidence: Closure is tamper evident
  • 1 L flexi-packs.Flexi pack (vaccine pack)Container: HDPEClosure: Homo polymer polypropyleneCap liner: Polyfaced steran wadTamper evidence: Aluminium foil seal
  • 2.5 L flexi-packs.Flexi pack (vaccine pack)Container: HDPEClosure: Homo polymer polypropyleneCap liner: Polyfaced steran wadTamper evidence: Aluminium foil seal
  • 5 L flexi-packs.Flexi pack (vaccine pack)Container: HDPEClosure: Homo polymer polypropyleneCap liner: Polyfaced steran wadTamper evidence: Aluminium foil seal
  • 1 L flexi-packs.Flexi pack (flat bottomed stand alone)Container: HDPEClosure: Copolymer polypropyleneCap liner: Polyfaced steran wadTamper evidence: Closure is tamper evident
  • 2.5 L flexi-packs.Flexi pack (flat bottomed stand alone)Container: HDPEClosure: Copolymer polypropyleneCap liner: Polyfaced steran wadTamper evidence: Closure is tamper evident
  • 5 L flexi-packs.Flexi pack (flat bottomed stand alone)Container: HDPEClosure: Copolymer polypropyleneCap liner: Polyfaced steran wadTamper evidence: Closure is tamper evident

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/142/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."